A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's Disease

Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

NCT00077779 ·Status: COMPLETED ·Phase: PHASE3

Special Investigation in Patients With Crohn's Disease (All Patients Investigation)

NCT01298648 ·Status: COMPLETED

Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

NCT00195715 ·Status: COMPLETED ·Phase: PHASE3

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

NCT00427921 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

NCT00409682 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

NCT00055523 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

NCT06023030 ·Status: RECRUITING

Remission in Subjects With Crohn's Disease, 1 Year Phase

NCT00055497 ·Status: COMPLETED ·Phase: PHASE3

Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115

NCT02185014 ·Status: COMPLETED ·Phase: PHASE3

A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

NCT00853099 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

NCT02015793 ·Status: COMPLETED ·Phase: PHASE2

A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease

NCT01243671 ·Status: COMPLETED ·Phase: PHASE3

Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to Severe Crohn's Disease With Previous Exposure to Infliximab (CHOICE)

NCT00338650 ·Status: COMPLETED ·Phase: PHASE3

Remission in Subjects With Crohn's Disease, Open Label Extension

NCT01070303 ·Status: COMPLETED ·Phase: PHASE3

A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease

NCT02039063 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD

NCT03059849 ·Status: WITHDRAWN ·Phase: PHASE4

Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon

NCT00348283 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806

NCT00686374 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

NCT01235689 ·Status: COMPLETED ·Phase: PHASE3

A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

NCT05394805 ·Status: COMPLETED

Efficacy and Safety of Adalimumab for the Induction of Clinical Response in Ulcerative Colitis

NCT01494857 ·Status: UNKNOWN ·Phase: PHASE3

Control Crohn Safe Trial

NCT03917303 ·Status: RECRUITING ·Phase: PHASE4

Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients

NCT01986127 ·Status: TERMINATED ·Phase: PHASE3

Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

NCT02450513 ·Status: COMPLETED

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease

NCT02065570 ·Status: COMPLETED ·Phase: PHASE3